Investors

Press Releases

Mar 12, 2018 8:30am EDT

iBio Patent Issues in China on Protein Glycosylation Modification

Mar 07, 2018 8:45am EST

iBio Expands Antibody Development and Production Services to Include Fc Fusion Therapeutics

Jan 05, 2018 5:00pm EST

iBio, Inc. Provides Corporate Update

Nov 30, 2017 4:15pm EST

iBio, Inc. Closes $4,500,000 Offering of Common Stock

Nov 29, 2017 9:00am EST

iBio, Inc. Prices $4,500,000 Firm Commitment Offering of Common Stock

Nov 28, 2017 5:07pm EST

iBio, Inc. Announces Proposed Public Offering of Common Stock

Nov 06, 2017 5:00pm EST

iBio, Inc. Initiates Litigation Against Fraunhofer-Gesellschaft in Delaware Chancery Court

Oct 30, 2017 8:30am EDT

iBio CDMO President to Co-Chair South African Molecular Pharming Conference

Oct 16, 2017 7:15am EDT

iBio Announces Manufacturing Collaboration with Aethlon Medical

Oct 02, 2017 8:30am EDT

iBio Appoints James Abbey, Ph.D. as Vice President of Strategic Business Development

Previous
1…
3
4
5
6
7
8
9
10
11
12
Next